SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $52,000 | -39.5% | 10,671 | -7.2% | 0.00% | – |
Q4 2021 | $86,000 | -25.9% | 11,498 | -10.8% | 0.00% | – |
Q3 2021 | $116,000 | -35.6% | 12,893 | -14.2% | 0.00% | – |
Q2 2021 | $180,000 | +19.2% | 15,025 | +24.5% | 0.00% | – |
Q1 2021 | $151,000 | -52.1% | 12,068 | -40.3% | 0.00% | – |
Q4 2020 | $315,000 | +48.6% | 20,215 | -9.8% | 0.00% | – |
Q3 2020 | $212,000 | +69.6% | 22,405 | +61.1% | 0.00% | – |
Q2 2020 | $125,000 | +64.5% | 13,906 | +15.8% | 0.00% | – |
Q1 2020 | $76,000 | -17.4% | 12,006 | +9.4% | 0.00% | – |
Q4 2019 | $92,000 | -34.8% | 10,975 | -29.8% | 0.00% | – |
Q3 2019 | $141,000 | +5.2% | 15,625 | +25.8% | 0.00% | – |
Q2 2019 | $134,000 | +7.2% | 12,425 | -5.3% | 0.00% | – |
Q1 2019 | $125,000 | -33.9% | 13,125 | -20.2% | 0.00% | -100.0% |
Q4 2018 | $189,000 | -28.4% | 16,440 | +5.4% | 0.00% | 0.0% |
Q3 2018 | $264,000 | +72.5% | 15,600 | +44.4% | 0.00% | – |
Q2 2018 | $153,000 | -23.5% | 10,800 | -67.1% | 0.00% | -100.0% |
Q3 2015 | $200,000 | -37.1% | 32,835 | +3.6% | 0.00% | -50.0% |
Q2 2015 | $318,000 | +68.3% | 31,685 | +202.9% | 0.00% | +100.0% |
Q1 2014 | $189,000 | – | 10,461 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |